Neuroimaging of Parkinson's
Trial
N/A
Recruiting
April 12, 2026
Genotypic Influences on Network Progression in Parkinson's Disease
Trial
N/A
Active, not recruiting
April 12, 2026
Ketamine for Veterans With Parkinson's Disease
Trial
Phase 2
Recruiting
April 12, 2026
Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
Trial
Phase 1
Completed
April 12, 2026
Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease
Trial
N/A
Recruiting
April 12, 2026
Effects of Stimulation Patterns of Deep Brain Stimulation
Trial
N/A
Enrolling by invitation
April 8, 2026
Quantitative Imaging of Brain Glymphatic Function in Humans
Trial
Early Phase 1
Active, not recruiting
April 8, 2026
Vestibulopathy as a Cause of Imbalance in Parkinson
Trial
Phase 1
Completed
April 8, 2026
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Trial
N/A
Enrolling by invitation
April 8, 2026
Etoricoxib in Patients With Parkinsonian Disease
Trial
Phase 2
Recruiting
April 7, 2026
Udall Project 1 Aim 4
Trial
N/A
Recruiting
April 7, 2026
Bacillus Subtilis in Parkinson's Disease
Trial
N/A
Completed
April 7, 2026
CPAP for the Treatment of Supine Hypertension
Trial
N/A
Recruiting
April 6, 2026
Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease
Trial
Phase 2
Completed
April 5, 2026
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
Trial
N/A
Recruiting
April 5, 2026
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
Trial
Phase 2
Completed
April 5, 2026
The Swedish BioFINDER 2 Study
Trial
N/A
Recruiting
April 5, 2026
Effectiveness of TeleVR App in Cognitive Decline and MCI Patients
Trial
N/A
Recruiting
April 2, 2026
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Trial
N/A
Recruiting
April 2, 2026
Sing For Your Saunter Part 2 R33
Trial
Phase 2
Completed
April 1, 2026